Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/27721
Title: Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.
Authors: King P.T.;Choong C.;Downey W.;Kelman A.;Baranyai E.;Francis M.;Moshinsky R.;Bardin P.G.;Holmes P.W.;Prodanovic Z.;Lim S. ;Ngui J.;Pick A. ;Holdsworth S.R. 
Institution: (King, Lim, Holdsworth) Monash University, Department of Medicine, Monash Medical Centre, 246 Clayton Rd, Clayton, Melbourne 3168, Australia (King, Bardin, Holmes) Respiratory and Sleep Medicine, Monash Medical Centre, Melbourne, Australia (Pick, Choong, Moshinsky) Department of Surgery, Monash Medical Centre, Monash University, Melbourne, Australia (Ngui) Clinical Immunology, Monash Medical Centre, Melbourne, Australia (Pick) Cardiothoracic Surgery, Cabrini Hospital, Melbourne, Australia (Downey, Baranyai) Cabrini Pathology, Cabrini Hospital, Melbourne, Australia (Prodanovic) Tissue Bank Service, MMC/Southern Health, Melbourne, Australia (Kelman) Southern Health Pathology, MMC/Southern Health, Melbourne, Australia (Francis) Microbiology, MMC/Southern Health, Melbourne, Australia
Issue Date: 10-May-2013
Copyright year: 2013
Publisher: Mosby Inc. (11830 Westline Industrial Drive, St. Louis MO 63146, United States)
Place of publication: United States
Publication information: Journal of Allergy and Clinical Immunology. 131 (5) (pp 1314-1321e14), 2013. Date of Publication: May 2013.
Abstract: Background: Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary inflammation that persists after the cessation of smoking. T cells have a major role in driving inflammation in patients with COPD and are activated by specific antigens to produce mediators, such as cytokines. The antigens that activate lung T cells have not been clearly defined. Nontypeable Haemophilus influenzae (NTHi) is the dominant bacterium isolated from the lungs of patients with COPD. Objective(s): We sought to measure the response of lung tissue T cells to stimulation with NTHi. Method(s): We obtained lung tissue from 69 subjects having lobectomies for lung cancer. Of the group, 39 subjects had COPD, and 30 without COPD were classified as control subjects. The lung tissue was dispersed into single-cell suspensions and stimulated with live NTHi. Cells were labeled with antibodies for 5 important inflammatory mediators in patients with COPD and analyzed by using flow cytometry. Result(s): NTHi produced strong activation of both TH cells and cytotoxic T cells in the COPD cohort. The COPD cohort had significantly higher levels of cells producing TNF-alpha, IL-13, and IL-17 in both T-cell subsets. When control subjects were divided into those with and without a significant smoking history and compared with patients with COPD, there was a progressive increase in the numbers of T cells producing cytokines from nonsmoking control subjects to smoking control subjects to patients with COPD. Conclusion(s): NTHi activates lung T cells in patients with COPD. This proinflammatory profibrotic response might be a key cause of inflammation in patients with COPD and has implications for treatment. © 2012 American Academy of Allergy, Asthma & Immunology.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.jaci.2012.09.030
PubMed URL: 23142009 [http://www.ncbi.nlm.nih.gov/pubmed/?term=23142009]
ISSN: 0091-6749
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/27721
Type: Article
Appears in Collections:Articles

Show full item record

Page view(s)

32
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.